IP discovery is a painkiller, not a vitamin: here are the five pain areas

Summary

Most companies treat IP discovery as something they should do – a vitamin. Something healthy, sensible, and easy to put off until next quarter. But across tax, transactions, people risk, licensing, and compliance, there are specific business events that make IP discovery non-optional. Events with deadlines, existing budgets, and consequences that dwarf the cost of acting. This article identifies five categories of pain that turn “should” into “must”, and explains why the budget for IP discovery already exists inside your company.

The vitamin illusion

We’ve spent two years telling companies they should understand their IP. Know your assets. Articulate your moat. Prepare for investment. All true. All sensible. And all remarkably easy to defer. Vitamins you could say.

But here’s what we’ve learnt from working with companies across sectors and stages: IP discovery doesn’t happen because someone reads an article. It happens because something forces it. An acquisition closes. HMRC writes a letter. A CTO resigns. A joint venture needs a background IP schedule. A licensing negotiation starts and nobody can answer the first question.

These aren’t hypothetical. They’re happening in boardrooms and deal rooms right now. And each one comes with three things: a deadline that someone else sets, a budget that already exists inside the company, and a cost of inaction that makes the engagement fee look trivial.

IP discovery isn’t a vitamin. It’s a painkiller. And here are the five pains.

1. The tax trigger

The pain: you’re paying tax on value that should be generating deductions

Tax is full of situations where companies must identify their intangible assets – or pay the price for not doing so. Acquisitions require purchase price allocation under IFRS 3, and anything not separately identified falls into goodwill – which is broadly not tax-deductible. R&D tax credit claims are being challenged by HMRC at unprecedented rates (up to 20%), and you can’t defend a claim without evidencing the IP your spend created. Multinationals face transfer pricing scrutiny under the OECD’s DEMPE framework, which demands a jurisdiction-by-jurisdiction map of intangible assets. And Patent Box elections – reducing corporation tax from 25% to 10% on qualifying profits – require mapping patent rights to specific income streams.

In every case, the budget already exists: PPA valuation fees, tax advisory retainers, R&D claim defence costs, transfer pricing compliance budgets. IP discovery isn’t a new line item. It’s an enhancement to work someone is already paying for.

Example – purchase price allocation: On a £100 million acquisition, a thorough IP discovery can surface millions in previously unidentified intangible assets – trade secrets, proprietary algorithms, specialist know-how – that move from the goodwill line (no tax relief) to separately valued intangibles (full amortisation relief). The result: annual tax savings of approximately £836,000, or £8.4 million over a decade. A £50,000 engagement generating seventeen times its cost in tax savings every single year.

The takeaway: if your company acquires businesses, claims R&D tax credits, operates across borders, or has qualifying patents, you already have a tax-driven obligation to know what IP you hold. The money you’re losing by not identifying it is real and quantifiable.

2. The transaction trigger

The pain: deals force the question – and punish you for not having the answer

Whether you’re buying, selling, raising, or listing, transactions create a deadline for IP discovery that someone else sets. PE and VC investors impose rigorous IP due diligence within compressed timelines. Carve-outs demand that every asset be attributed between the retained and divested businesses. In each case, the budget already exists – buy-side legal fees, vendor due diligence budgets, IPO advisory costs.

Example – M&A due diligence: Intangible assets now represent approximately 92% of company value, yet 83% of global intangible value is not disclosed on balance sheets. Traditional IP due diligence addresses the visible fraction: patents, registered trademarks, material licences. The majority is not visible – e.g. trade secrets, proprietary know-how, undocumented software – is cursorily reviewed or ignored. This surfaces as ownership gaps, undocumented dependencies on key people, and trade secret vulnerability. Due diligence that should take eight weeks takes six months. Buyers lose confidence. Valuations get haircut.

The takeaway: if you’re buying, selling, raising, or listing, IP discovery is already on the critical path. The question is whether you do it proactively or scramble under time pressure / leak value.

3. The people trigger

The pain: your biggest risk walks on two legs

When key people or entire teams leave, companies need to know what trade secrets those people had access to – and prove it to a court if necessary. Without a documented trade secret inventory, injunctions fail. In Double Eagle Alloys v Hooper, a departing employee downloaded 2,660 files, yet the case was dismissed because the company couldn’t identify its trade secrets with sufficient particularity.

Example – the cases you already know: Rippling v Deel, Palantir v Guardian AI, Scale AI v Mercor, Google v Ding. In every case, the outcome hinges not on whether secrets were taken – but on whether the company had identified and documented them beforehand. 72% of employees take material when they leave. A pre-emptive trade secret audit costs £15,000–£75,000. Emergency injunction applications cost £50,000–£150,000. Full litigation runs to millions. The audit is a fraction of the litigation spend, but it’s the fraction that determines whether you win or lose.

The takeaway: if you employ people who know things that matter, you need to have identified what those things are before they leave. Not after. Before.

4. The revenue trigger

The pain: IP you haven’t identified is IP you can’t monetise

Licensing opportunities – particularly in AI – are creating substantial new revenue streams for companies that can clearly articulate what they own. But companies that don’t know what IP they have accept whatever terms are offered. Those with documented, segmented IP portfolios negotiate significantly better deals. The EU AI Act now requires general-purpose AI model providers to comply with EU copyright law, making IP audits essential for content owners.

Example – licensing the full bundle: Most technology licensing deals are structured around registered IP, because that’s what companies know they own. But the commercial value often sits in unregistered IP: manufacturing know-how, proprietary datasets, training methodologies. A pharmaceutical company licensing a drug manufacturing patent for £1 million per year could licence the full bundle – process data, failure-mode documentation, batch-specific know-how – for £3–5 million. The patent gives the right to make it; the know-how gives the ability to make it efficiently.

The takeaway: if someone else could pay to use what you’ve built, you need to know precisely what you own before you sit down at the table.

5. The compliance trigger

The pain: regulators are asking, and “we haven’t looked” isn’t an answer

Regulatory regimes increasingly require companies to identify their intangible assets – or face serious consequences. Export controls criminalise sharing controlled technology with foreign nationals without classification. Directors’ duties require care over assets representing over 92% of market capitalisation. The UK Corporate Governance Code 2024 explicitly addresses innovation and asset management at board level. Other jurisdictions are similar.

Example – export controls: The Export Control (Amendment) Regulations 2024 introduced controls on semiconductors, quantum computing, AI technology, and additive manufacturing. A “deemed export” occurs when controlled technology is shared with a foreign national – even verbally. The penalties: unlimited fines and up to ten years’ imprisonment. In the first half of 2024, HMRC imposed a penalty exceeding £1 million for a single violation. Companies cannot comply with export controls unless they have identified and classified their controlled technology and know-how.

The takeaway: if you operate in defence, deep tech, AI, or any regulated sector, ignorance of your own IP isn’t just risky – it’s potentially criminal. And for every company with a board, the governance obligation to know what you own is becoming harder to ignore.

The pattern

Every one of these five pains shares three features.

A deadline that someone else sets. The IFRS 3 measurement period. The HMRC enquiry letter. The notice period before your CTO joins a competitor. The DD window on a transaction. The export licence application. None of these wait for you to get organised.

A budget that already exists. The PPA valuation fee. The legal due diligence workstream. The litigation budget. The licensing advisory retainer. The compliance programme. In every case, IP discovery is not a new line item – it’s an enhancement to work someone is already paying for.

A cost of inaction that dwarfs the cost of acting. £8.4 million in foregone tax savings. A deal that collapses or gets discounted. A failed injunction. Revenue left on the table. Criminal liability. Against these, the cost of IP discovery is not even a rounding error.

The question is no longer “should we understand our IP?” It’s “which of these five triggers is approaching next – and are we ready?”

What this means for you

If you’re a founder, exec, or board member, you’ve probably got one of these triggers approaching right now. Perhaps more than one. The good news: getting ahead of it is fast, light-touch, and dramatically cheaper than dealing with the consequences after the event.

We built Intanify precisely for this – to make comprehensive IP discovery something that takes days, not months, and costs a fraction of what’s at stake. Whether you’re preparing for a transaction, defending a tax claim, protecting against departures, exploring licensing opportunities, or getting your governance house in order, the starting point is always the same: know what you own.

Identify your top five assets for free here: intanify.com/company